Biogen Idec was founded during 2003 with its headquarters located in Cambridge, MA following the amalgamation of the couple of most forerunner biotechnological companies in the world known as Biogen Inc which was founded during 1978 and IDEC Pharmaceuticals Corporation which was established during 1985. James Mullen ex-Chairman-cum-CEO of the then Biogen Inc., is the CEO and President serving since November 2003.

 

The company is devoted to maintaining its most advanced research centers at San Diego, CA and in Cambridge, MA. Biogen Idec possesses the offices in various other nations like Canada, Australia, and Japan besides almost all over the European Union which incorporates the international headquarters at Zug in Switzerland, managing the global network covering more than 70 nations. The work force of the company now is around 3,900 heads scattered all over the world.   

 

The company works through scientific brilliance for attaining fresh values of care drives and as the result more than 20 products are now being offered by the company in clinical development directing an array of vital medical requirements. In addition to the company’s potential range of drug applications, the capabilities and capacities of the company for producing protein are top-notch in quality and degree.

 

The company has three authenticated and devoted biological bulk-producing facilities which incorporate its giant production unit in Research Triangle Park, NC, which is one of the prevalent cell culture facilities. Besides this, another giant production unit is being erected at Hillerod, Denmark.  

 

The key authentic products of the company include: Intron-A, Engerix-B, Recombivax and Angiomax.